Digital health and wellness startup Briota Technologies offers a holistic digital therapeutics platform that seeks to simplify the diagnosis and management of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease (ILD), long Covid, and post-Tuberculosis diseases.

Founded by Gajanan Sakhare and Shardul Joshi, Briota is on a mission to help 10 million people improve lung health by 2030. Its cutting edge Spirometry at Home service leverages an AI and IoT-first approach to democratise the diagnosis and lifecycle management of chronic respiratory ailments. The Healthtech startup's intuitive, affordable solutions arm patients and caregivers with accurate, real-time data needed to equip doctors to make better decisions, right from treatment solutions to medication adjustments, and enable caregivers to ensure better monitoring and

Briota's homegrown innovation has already helped over 55,000 patients, who are mostly from underserved populations in India. The company, which is currently operational in India and Denmark, is growing its global presence through various partnerships signed with governments, foundations, pharma, and insurance companies.

Every 30 seconds, one leg is amputated due to diabetes. Medtech startup Ayati Devices wants to change that. The company is on a mission to reduce the risk of foot amputations due to diabetes by enabling early diagnosis through timely and accurate detection of diabetic peripheral neuropathy in patients. Founded by Nishant Kathpal, Ayati's maiden product Vibrasense is a low-cost, portable, smart screening device that can detect the severity of foot neuropathy in patients with type 1 and 2 diabetes.

Its new solution Angiocam is a laser-based, non-invasive imaging device that provides real-time video images of microvascular perfusion. Through this device, surgeons will be able to evaluate and quantify microcirculation in the foot and monitor the healing process of diabetic foot ulcers. It will also enable doctors to ensure better and quicker decision-making related to limb salvage potential, determine need for referrals for vascular interventions, and to objectively document improvements in microcirculation after vascular interventions. For patients, the benefits include reduced risks of amputations, treatment cost savings, and remote monitoring of wounds.

Dementia is a debilitating condition that affects millions of people worldwide, with an estimated 44 out of 4.5 million people in India alone suffering from it. UrvogelBio, a pioneering Healthtech startup, is dedicated to advancing neuro care with a particular emphasis on Alzheimer's disease and related dementias.

The startup's cutting-edge platform employs exosome-based diagnostics and genetic testing to enable personalized treatment through early and easy detection of neurological diseases. It also offers patients access to minimally invasive, comprehensive early age treatments that slow the progression of neuro diseases.

Founded by Dr. M.V. Sasidhar and Co-founder Dr. Subhashani Prabhakar, UrvogelBio's portfolio of diagnostic tests extends to Alzheimers, Multiple Sclerosis, Parkinson's disease, and stroke diagnostics, using neuronal exosome profiling and cell-free DNA.

Neodocs has developed an instant at-home smartphone-based health test platform that lets users take lab tests, anywhere and anytime, for a variety of metabolic and infectious diseases and get their results in 30 seconds.

The company, which is currently live with five urine test kits, designs custom test cards that contain highly specific biochemistries that give a visual output in terms of change in colour or intensity at the end of reaction. As part of the test, patients need to dip a custom test card in urine for a second, then take a photo of it using the Neodocs app, following which an algorithm uses computer vision to scan the card for biomarkers and give the test results in 30 seconds.

The company's current test portfolio includes urinary tract infection screening test, kidney care, antenatal pregnancy care, and elderly care. Going forward, the startup is looking to expand beyond urined-based tests to include tests based on blood, saliva, sweat, semen, and vaginal discharge. Over the next 12 months, its test pipeline is expected to increase to include Vitamin-D, IgE, Malaria, and HbA1c.

Primary Healthtech has developed a portable and affordable multi-diagnostic device, 'Mobilab' that is capable of analysing more than 25 parameters for diagnosis of kidney, liver, pancreas, and heart problems, among other things. With the goal of providing comprehensive healthcare solutions for all, Primary Healthtech's patented technology makes use of nanotechnology, advanced optics and optimised algorithms for performing diagnostic tests at low volume with better accuracy. With Mobilab, patients can access comprehensive healthcare at 20x reduced cost compared to traditional diagnostic methods. The device further supports 21 Indian languages, making it accessible to a diverse population.

Mobilab's efficacy has been demonstrated through seven hospital trials and 10,000 patient samples that it has so far collected. Also, currently Primary Healthtech holds seven patents that is a clear reflection of their cutting-edge approach to healthcare technology.

With over 5 billion screen users, nearly half of India's urban population is expected to be affected by dry eye disease by 2030. To address this need, healthcare startup Autoyos is providing efficient, affordable, accessible, and scalable eye screening and diagnosis solutions by leveraging autonomous systems and AI technology. Founded by Bharathkumar Hegde and Vijayashri B Nagavi, the startup - which has developed an advanced analysis and management platform through its innovations iDEA (Intelligent Dry Eye Analyser) and mobile app EyeD - seeks to enable caregivers to reach 10x more dry eye patients at one-tenth of the cost in one-fifth of the time to deliver evidence-based care.

Autism, ADHD, intellectual delays, and learning disabilities affect 20 percent of the 25 million newborns in India and 125 million globally but lack of clinicians, affordability, and infrastructure challenges result in poor management of autism and other developmental disorders. To address this need, Healthtech startup CogniAble provides end-to-end clinical and digital services for caregivers of special needs children to ensure better quality of life through home-based, center-based, and online interventions.

Founded by Manu Kohli, Dr. Swati Kohli, along with Dr. Joshua Pritchard and Dr. Prathosh AP, the startup leverages machine-learning-based assistive technology to detect and deliver individualized interventions and digital therapy management for the treatment of autism spectrum disorder. The startup's multidisciplinary team of pediatricians, applied behaviour analysis (ABA) therapists, occupational therapists, speech and language therapists, physiotherapists, and special educators provide services in 12+ Indian locations. So far, it has conducted around 2,00,000 sessions and 50,000 screenings.

Pressure injuries account for over 1.4 million cases of deaths in India. In addition, around 80 percent of nurses reported musculoskeletal pain due to patient handling, as they potentially lift a cumulative 1.8 tons of weight during an eight-hour shift. To address these two problems, startup Cureous Labs has developed Eturnal, an automatic patient repositioning overlay system, capable of turning the patient to stable sleep positions. In doing so, it helps ensure effective pressure shifting and redistribution, and allows nurses to provide data-driven care without the need for resource-intensive manual patient handling by them.